Philips, Elekta start to install MRI-guided linear accelerator for next-gen cancer imaging, treatment

Partners Royal Philips ($PHG) and Elekta ($EKTA) have started installing a high-field, MRI-guided linear accelerator system at The Netherlands Cancer Institute in Amsterdam. The Institute is part of a consortium founded in 2012 by Elekta and Philips that's slated to make these sorts of systems, known as MR-linac, the standard of care for cancers that are not well controlled. The system uses a high-field MRI scanner to observe patient anatomy in real time, then it targets tumor tissue while minimizing exposure to the radiation beams for surrounding, normal tissue. "The clinical effectiveness of radiation treatment depends highly on the quality and accuracy of radiotherapy guidance and delivery," said Rob Cascella, CEO Imaging Businesses at Philips, in a statement. "In securing that quality and accuracy, MR imaging is emerging as a promising oncology tool for disease localization and quantification, therapy planning, treatment guidance, and therapy assessment. Through the collaboration with Elekta and the consortium partners such as The NKI, I am convinced that we have the prerequisites to make MR-guided radiotherapy a meaningful success for both patients and care providers." More

Suggested Articles

Grail published new data showing that its cancer-screening blood test is now able to spot more than 50 types of the disease and across all stages.

Battelle received an emergency go-ahead from the FDA over the weekend to deploy its decontamination system for N95 respirator masks.

The limited supply of ventilators is one of the chief concerns facing hospitals as they prepare for more COVID-19 cases.